Hunan Er Kang Pharmaceutical (300267) — Cash Flow Reinvestment Rate
Hunan Er Kang Pharmaceutical (300267) has a Cash Flow Reinvestment Rate of 0.46x as of June 2023, reinvesting CN¥80.56 Million (capex CN¥45.68 Million plus investments CN¥34.88 Million) from operating cash flow of CN¥174.55 Million. Explore capital reinvestment ratio of Hunan Er Kang Pharmaceutical to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hunan Er Kang Pharmaceutical Cash Flow Reinvestment Rate (2008–2024)
Historical reinvestment intensity for Hunan Er Kang Pharmaceutical across 17 annual periods. Also explore how large is Hunan Er Kang Pharmaceutical's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hunan Er Kang Pharmaceutical (2008–2024)
Year-by-year capital reinvestment analysis for Hunan Er Kang Pharmaceutical. For live market cap and broader valuation context, see Hunan Er Kang Pharmaceutical market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.11x | CN¥517.75 Million | CN¥166.69 Million | CN¥195.60 Million | ▲ +34.4% |
| 2023 | 2.31x | CN¥343.11 Million | CN¥148.42 Million | CN¥238.19 Million | ▲ +137.5% |
| 2022 | 0.97x | CN¥273.49 Million | CN¥281.02 Million | CN¥173.49 Million | ▼ -87.2% |
| 2021 | 7.60x | CN¥704.27 Million | CN¥92.68 Million | CN¥349.33 Million | ▲ +27.7% |
| 2020 | 5.95x | CN¥1.06 Billion | CN¥178.53 Million | CN¥605.89 Million | ▲ +431.5% |
| 2019 | 1.12x | CN¥498.88 Million | CN¥445.82 Million | CN¥364.21 Million | ▼ -40.1% |
| 2018 | 1.87x | CN¥231.39 Million | CN¥123.89 Million | CN¥96.72 Million | ▲ +269.0% |
| 2017 | 0.51x | CN¥348.81 Million | CN¥689.11 Million | CN¥258.92 Million | ▼ -80.8% |
| 2016 | 2.64x | CN¥1.29 Billion | CN¥486.50 Million | CN¥1.15 Billion | ▲ +140.4% |
| 2015 | 1.10x | CN¥570.53 Million | CN¥518.96 Million | CN¥570.53 Million | ▼ -63.4% |
| 2014 | 3.01x | CN¥527.42 Million | CN¥175.38 Million | CN¥527.42 Million | ▲ +156.9% |
| 2013 | 1.17x | CN¥203.98 Million | CN¥174.22 Million | CN¥203.98 Million | ▼ -57.5% |
| 2012 | 2.75x | CN¥231.28 Million | CN¥84.02 Million | CN¥231.28 Million | ▲ +375.1% |
| 2011 | 0.58x | CN¥43.87 Million | CN¥75.72 Million | CN¥43.87 Million | ▼ -62.2% |
| 2010 | 1.53x | CN¥65.05 Million | CN¥42.47 Million | CN¥65.05 Million | ▼ -20.6% |
| 2009 | 1.93x | CN¥19.64 Million | CN¥10.18 Million | CN¥19.64 Million | ▼ -96.8% |
| 2008 | 59.81x | CN¥12.62 Million | CN¥211.00K | CN¥12.62 Million | — |